Assessment of the efficacy of a local steroid rescue treatment administered 2 days after a moderate noise-induced trauma in guinea pig by Mamelle, Elisabeth et al.
HAL Id: hal-02111940
https://hal.archives-ouvertes.fr/hal-02111940
Submitted on 17 May 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Assessment of the efficacy of a local steroid rescue
treatment administered 2 days after a moderate
noise-induced trauma in guinea pig
Elisabeth Mamelle, Naila El Kechai, Victor Adenis, Yann Nguyen, Olivier
Sterkers, Florence Agnely, Amélie Bochot, Jean-Marc Edeline, Evelyne Ferrary
To cite this version:
Elisabeth Mamelle, Naila El Kechai, Victor Adenis, Yann Nguyen, Olivier Sterkers, et al.. Assess-
ment of the efficacy of a local steroid rescue treatment administered 2 days after a moderate noise-
induced trauma in guinea pig. Acta Oto-laryngologica, Taylor & Francis, 2018, 138 (7), pp.610-616.
￿10.1080/00016489.2018.1438659￿. ￿hal-02111940￿
For Peer Review Only
Assessment of the efficacy of a local steroid rescue 
treatment administered 2 days after a moderate noise-
induced trauma in guinea pig 
Journal: Acta Oto-Laryngologica 
Manuscript ID SOTO-2017-0576 
Manuscript Type: Regular 
Classification Scheme: inner ear 
Keywords: Dexamethasone phosphate; guinea pigs; hearing loss; noise-induced; hydrogel; liposomes 
http://mc.manuscriptcentral.com/soto  Email: actaoto@informa.com
Acta Oto-Laryngologica
For Peer Review Only
1
Assessment of the efficacy of a local steroid rescue treatment administered 2 days after a 
moderate noise-induced trauma in guinea pig 
A local treatment after noise trauma in guinea pig 
Abstract 
Objectives: Intratympanic injection of corticosteroids membrane after noise-induced hearing 
loss is an accepted alternative to general administration. We investigated the effect on hearing 
of a hyaluronic acid gel with liposomes loaded with dexamethasone (DexP) administered into 
the middle ear.  
Methods: An acute acoustic trauma was performed to 13 guinea pigs for a period of 1 hour on 
Day–2. Two 2 days after the noise trauma, the animals were then assigned randomly to four 
experimental groups: control without gel, gel injection, gel containing free DexP, gel 
containing DexP loaded into liposomes. Auditory thresholds were measured with Auditory 
Brainstem Response before Day-2 and at Day 0, Day 7 and Day 30 after noise trauma.  
Results: Seven days after, a complete hearing recovery was observed in the control group at 
all frequencies apart from 8 kHz, and no recovery was observed in the three groups receiving 
a gel injection. Thirty days after trauma, all of the animals had recovered normal hearing, 
apart from at the 8-kHz frequency, with similar auditory thresholds.  
Conclusions: Local DexP administration 48 h after a mild acoustic trauma did not improve 
hearing recovery, even with a sustained release in a specific gel formulation designed for 
inner ear therapy. 
Key words: Dexamethasone phosphate; guinea pigs; hearing loss; noise-induced; hydrogel; 
liposomes 
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Introduction 
Exposure to intense noise is frequently associated with non-genetic (acquired) hearing loss in 
adult subjects. The traumatizing noise may be continuous, repetitive impulsive (industrial 
noises), or pure impulsive (explosions, gunshots)[1]. Acute acoustic trauma leads to 
mechanical and metabolic damage to the cochlea. The mechanical damage is due to excessive 
movements of the basilar membrane leading to loss of hair cells, impaired stereocilia, and 
collapse of supporting cells[2]. The subsequent metabolic damage includes ionic disorders 
involving an intracellular influx of potassium or calcium, excitotoxicity following excessive 
release of glutamate, and oxidative stress due to the production of free radicals[3]. These 
mechanisms can lead to relatively rapid cell death by necrosis and/or apoptosis. Part of the 
initial noise-induced hearing loss is only temporary, and may recover as a result of cochlear 
repair mechanisms[3, 4]. However, exposure to impulse noise typically results in substantial 
permanent hearing loss. 
At a clinical level, common treatments after noise-induced hearing loss consist of resting in a 
silent environment, administration of corticosteroids which may or may not be associated with 
vasodilator drugs, antioxidant drugs, hyperbaric oxygen therapy or normovolemic 
hemodilution[1]. Various pharmacologic compounds such as corticosteroids, apoptosis 
inhibitors, and antioxidants have been tested in animal models with various levels of noise-
induced hearing loss[1, 2]. In these noise trauma animal models, therapies have been 
administered either before or after noise exposure, and these were effective to varying degrees 
with regard to hearing protection. 
In an earlier study, we demonstrated that a liposomal hyaluronic acid gel loaded with 
dexamethasone phosphate (DexP) injected into the middle ear of guinea pigs resulted in a 
high drug concentration in the perilymph as well as a sustained release of the drug for up to 
30 days[5]. The aim of the present study was to determine whether this local treatment could 
have a therapeutic effect in guinea pigs when applied 2 days after a moderate acoustic trauma, 
Page 2 of 19
http://mc.manuscriptcentral.com/soto  Email: actaoto@informa.com
Acta Oto-Laryngologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 3
a clinically relevant condition. 
 
Materials and methods 
Animals 
Thirteen male Hartley albino guinea pigs (Charles River, L’Arbresle, France) were used in the 
study weighing 300–500 g with auditory thresholds in the normal range[6]. Animal care and 
experimental procedures were conducted in accordance with the guidelines established by the 
European Communities Council Directive (2010/63/EU Council Directive Decree), and were 
approved by the local ethics committee (N° AP 2014-23). 
Study design (Fig. 1) 
Fig. 1 Experimental protocol near here 
 
After the initial determination of the auditory threshold by Auditory Brainstem Responses 
(ABR), all of the animals were subjected to noise-exposure at D-2. Two days later, at D0, the 
audiogram was re-tested with ABR to evaluate the hearing loss induced by the acoustic 
overexposure. Following this post-trauma ABR test, animals were assigned randomly to four 
experimental groups: 
1. control without gel injection but with the bulla opened (eight ears), 
2. hyaluronic acid gel injection without DexP (HA; six ears), 
3. hyaluronic acid gel containing free DexP (HA-DexP; six ears), 
4. hyaluronic acid gel containing DexP loaded into liposomes (HA-DexP-Lip; five ears). 
In all the animals in these groups, both ears were used and each ear was considered to be an 
independent measurement. In the HA-DexP-Lip group, one animal had only one ear injected 
with the gel (which explains the odd number of ears in this group). The hearing thresholds 
were recorded again at Day 7 (D7) and Day 30 (D30) for all groups. 
Materials 
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Dexamethasone sodium phosphate (DexP, Mw 516.4 Da, purity 98%) was obtained from 
Fagron (Amsterdam, The Netherlands). Egg phosphatidylcholine (EPC, purity 96%) was 
provided by Lipoid GmbH (Ludwigshafen, Germany). Cholesterol (Chol) was purchased 
from Sigma–Aldrich Co. (St Louis, MO, USA). 1,2-Distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy-poly-(ethyleneglycol) 2000] (DSPE-PEG2000, purity > 
99%) was obtained from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Sodium hyaluronate 
(HA, Mw 1.5 MDa, purity 95%) was provided by Acros Organics (New Jersey, USA). All 
other chemicals were of analytical grade. 
Preparation of hyaluronic acid (HA) gel formulations 
DexP-loaded PEGylated liposomes (DexP-Lip) were prepared by the thin film method as 
previously described[7]. Briefly, lipid film composed of EPC:Chol:DSPE-PEG2000 (60:35:5 
mol%) was prepared using rotary evaporation. The lipid film was hydrated with 100 mg/mL 
DexP solution in Milli-Q water. The liposome suspension was extruded to achieve a final size 
of 140 nm. Non-encapsulated DexP was eliminated by dialysis using cellulose dialysis 
membranes with a molecular weight cut-off of 15 kDa (Spectrum Laboratories, Inc, CA, 
USA) against HEPES/NaCl buffer (10/115 mM, pH 7.4) at 4°C for 48 h with repeated 
changes of buffer and protection from light. The mean encapsulation efficiency for DexP-Lip 
was 182 ± 30 mg DexP/g lipid. 
HA and HA-DexP gels were prepared by dissolving HA (2.28% w/v) in HEPES/NaCl buffer 
(10/115 mM, pH 7.4) and in 10 mg/mL of DexP solution, respectively (DexP dissolved in 
HEPES/NaCl buffer 10/115 mM, pH 7.4). For the preparation of liposomal gel (HA-DexP-
Lip), HA (2.28% w/v) was dissolved in the liposome suspension at 80 mM final lipid 
concentration with a DexP concentration of 10 mg/mL. The gels were then homogenized by 
vortex mixing for 5 min, maintained at room temperature for 1 h and then stored at 4°C for at 
least 12 h before in vivo injection. 
Exposure to traumatic sound 
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Animals, placed individually in a wire mesh cage (23 x 23 x 15 cm), were exposed for 1 h to a 
traumatic tone (5 kHz pure tone, 100 dB SPL) in an acoustically isolated chamber (IAC 
model AC2). The pure tone was generated by a wave generator (Hewlett-Packard, model HP 
8903B), amplified (Prism-Audio, model LA-150M) and sent to two piezoelectric tweeters 
(Motorola, model KSN 1005) located on each side of the cage. The sound delivery system 
was calibrated to obtain 100 ± 5 dB at various locations in the cage, verified by a calibrated 
type I precision sound level meter (B&K model 2235). As in a previous study[8], visual 
inspection of the animal during exposure indicated that there was no preferred orientation of 
the animal with regard to the speakers. 
Audiograms determined from Auditory Brainstem Response (ABR) 
The audiograms from the guinea pigs were evaluated by recording the ABR following an 
auditory stimulus. The ABR test was performed on both ears before acoustic trauma (D-2) and 
after trauma (D0, D7, and D30), under gas general anesthesia (isoflurane). Tone bursts of 50 ms 
duration were delivered at 1, 4, 8, 16, 24, and 32 kHz, by a high frequency transducer 
(Etymotic Research ER1) connected to an external ear canal probe. The ABR were recorded 
via subcutaneous electrodes (SC25, Neuro-Services) placed subcutaneously in the leg, the 
vertex, and the ipsilateral retro-auricular side of the analyzed ear. The ABR were collected 
using a commercial interface and software (RT Otophy Lab, Echodia, France), and were 
determined from 80 dB, with 5 dB decreasing steps. The thresholds corresponded to the 
minimal intensity for which an ABR wave (usually wave 3) was clearly detected. To 
minimize the use of animals (according to the 3R rule), both ears from each animal were used, 
and each ear was considered to be an independent repetition. 
Injection procedure 
Gel injection into the middle ear (HA, HA-DexP or HA-DexP-Lip) was performed at D0, 
under general gas anesthesia (isoflurane). Body temperature was maintained around 37°C by 
a controlled heating tap. To guarantee precise application of the gel on the round window 
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under microscopic view, the gel was injected into the middle ear after a surgical approach 
instead of a direct intratympanic injection. The retro-auricular skin was shaved and cleaned 
with povidone-iodine. Local anesthesia was administered by the injection of lidocaine 
hydrochloride (0.5 mL, 1%) into the subcutaneous tissues to complete the general anesthesia. 
After a retro-auricular incision, the muscles were gently pushed aside from the bone and the 
tympanic bulla was carefully opened using a 2-mm diamond bur to drill the bone (Collin, 
NSK, Nakashima, Japan) allowing visualization of the cochlea as well as the round window. 
The gel was injected using a 1 mL syringe equipped with a 29 G needle (diameter = 0.16 mm, 
length = 88 mm, B. Braun). The volume of gel injected was 150 ± 20 µL (DexP dose: 1.5 ± 
0.2 mg), depending on the size of the bulla. This procedure was performed under binocular 
loupe to inject the gel on the round window, and then to completely fill the bulla. The muscle 
and skin were then sutured with a 3.0 Vicryl suture (Ethicon, Cincinnati, OH, USA). After the 
injection procedure, the guinea pigs received an intramuscular injection of antibiotic 
prophylaxis (Enrofloxacine Bayer, Leverkusen, Germany). A general analgesic (Tolfedine 1 
mg/kg i.p.) was delivered at the end of surgery. In control animals, the same surgical 
procedure was performed but without any gel injection. 
Statistical analysis 
Results are expressed as mean ± SEM. GraphPad Prism 7 software was used for statistical 
analysis. Non-parametric tests were performed, and statistical analysis of the hearing 
thresholds was conducted using two-way or one-way analysis of variance (ANOVA), with 
Tukey’s post-hoc test. A p value < 0.05 was considered to be statistically significant. 
 
Results 
Before noise exposure (D-2), auditory thresholds determined between 1 and 32 kHz were in 
the range of what has previously been described in guinea pigs[6]. Auditory thresholds, before 
noise exposure, were equivalent among the individuals and between groups (two-way 
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ANOVA, ns; Fig. 2). Two days after noise exposure, a noise-induced threshold shift (D-2 vs. 
D0) was observed at all frequencies apart from 1 kHz, and was similar between the different 
experimental groups (Fig. 2). The mean hearing loss recorded at 8 kHz was 29 ± 3 dB, and at 
16 kHz, it was 24 ± 3 dB. For 4, 24 and 32 kHz, a hearing loss around 15 dB was observed 
(14 ± 2 dB, 14 ± 3 dB and 16 ± 2 dB, respectively). 
 
Fig. 2 Pre- and post-trauma ABR thresholds near here 
 
Seven days after noise-exposure (D7), a total recovery of the thresholds was observed in the 
control group at 4, 16, 24 and 32 kHz (Fig. 3). However, a 23 ± 4 dB hearing loss was still 
observed at 8 kHz (two-way ANOVA, p<0.0001). In the other groups, in which gel was 
applied in the bulla, whatever the formulation (HA, HA-DexP or HA-DexP-Lip), no recovery 
was observed at D7: ABR thresholds were similar to the post-trauma ABR thresholds 
measured at D0 at all frequencies (two-way ANOVA, ns; Fig. 3). 
 
Fig. 3 Post-trauma thresholds at D7 (solid black line) near here 
 
One month after the trauma (D30), total recovery was observed in all groups compared to pre-
trauma thresholds (apart from 8 kHz frequency in each group), with no differences among all 
groups (Fig. 4). In the control group, at 4, 16, 24 and 32 kHz frequencies, ABR thresholds 
remained stable at D30, compared to D7, with no difference compared to pre-trauma ABR 
thresholds (two-way ANOVA, ns; Fig. 4). At 8 kHz, the hearing loss was 20 ± 3 dB for the 
control group, 15 ± 6 dB for the HA group, 14 ± 7 dB for the HA-DexP group, and 13 ± 5 dB 
for the HA-DexP-Lip group. 
 
Fig. 4 Post-trauma thresholds at D30 (solid black line) near here 
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Discussion 
In the present study, acoustic traumas were performed on guinea pigs to test the efficacy of 
DexP when delivered from a local gel 2 days after noise exposure. Guinea pig is a model 
commonly used to study hearing disabilities because hearing thresholds are age-dependent 
when evaluated 1 month after birth (Table 1)[6, 9]. However, there are differences in hearing 
between pigmented and albino guinea pigs. Albino guinea pigs usually have lower hearing 
than pigmented guinea pigs, especially in the midfrequencies[10]. Thus, the albino model 
might experience poorer recovery probably related to the properties of the stria vascularis 
which lacked melanin and showed a different glutathione distribution[10, 11]; however, this 
point remains under debate because similar noise trauma experiments performed in both 
models showed higher hearing loss in pigmented guinea pigs (Table 1)[11–14]. 
With the acoustic trauma performed in the present experimental protocol, a temporary 
threshold shift was observed at most frequencies apart from 8 kHz, which showed a 
permanent threshold shift of 20 dB at 7 and 30 days in the control group. These data are 
consistent with those of Gourévitch et al., who demonstrated that a single trauma could 
produce a temporary threshold shift restricted to 6–9 days[8]. Indeed, initial noise-induced 
hearing loss can partially recover with cochlear repair mechanisms that promote cell recovery, 
and antioxidant intracellular reactions of defense mechanisms[4].  
The acoustic trauma delivered in this study was centered on the 5 kHz frequency which 
usually leads to a threshold shift an octave above the frequency of the traumatic sound[15]. 
More severe noise traumas (>105 dB) were usually performed in other studies to test 
corticosteroid efficacy in albino guinea pigs, with various duration times from 20 min to 48 h 
(Table 1). Harrop-Jones et al. found greater temporary ABR thresholds with a 2 h acoustic 
trauma (narrow bandpass 4–8 kHz) at 105 dB, similar to the present noise trauma, especially 
at 4 and 16 kHz, with hearing losses around 40–50 dB and 40–20 dB, respectively [16]. 
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Interestingly, they demonstrated a benefit from the OTO-104 gel (6% dexamethasone in 
poloxamer gel) 10 days after the trauma at 4 kHz but not 8 kHz, when it was injected 2 days 
after noise exposure, and at 8 kHz when OTO-104 was injected 3 days after trauma. When the 
OTO-104 gel was applied before noise exposure, otoprotection was demonstrated at 4, 8 and 
16 kHz frequencies with the two-noise trauma paradigms tested: 2 h at 105 dB or 110 dB. In 
their study, only 50 µl gel was injected through the tympanic membrane whereas the present 
protocol used a retroauricular approach to fill the whole bulla (around 150 µl). 
Table 1 near here 
In contrast to invasive systems such as an osmotic pump, which could deliver high 
dexamethasone concentrations locally for outer hair cell protection[1, 17], the local drug 
delivery system tested in the present study was specific HA gels delivering DexP. They were 
designed for inner ear therapy, with two different kinetic release mechanisms. Indeed, the HA 
gels could achieve longer residence times in the middle ear in contact with the round window 
whereas the liquid solution usually injected is rapidly evacuated through the Eustachian 
tube[7]. Furthermore, one gel injection could ensure a longer release delivery into the bulla 
and thus could avoid repeated injections. DexP loaded into liposomes contained within HA 
gel has been shown to ensure a sustained release with elevated concentrations for up to 30 
days, compared to free DexP within HA gel, which could be released for up to 15 days[5]. 
Nevertheless, in the present noise-induced hearing loss procedure, similar spontaneous 
hearing recovery was observed in the treated animals compared to non-treated ones. 
Moreover, in animals with gel injections, a delayed recovery was observed at D7, compared to 
the control group, which could be due to a conductive hearing loss induced by the gel 
viscosity that filled the whole bulla and surrounded the traumatized ossicular chain. These 
rheological behaviors and the presence of the gel at D7 around the ossicular chain that was 
overexposed to noise[5] may explain the delay in recovery observed in the three experimental 
groups. 
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The use of corticosteroids for hearing protection during noise over-exposure in animals has 
been widely described in the literature (Table 1); however, there was some discrepancy with 
regard to their success in hearing recovery. When dexamethasone was administered locally at 
different concentrations before noise exposure, efficient hearing thresholds could be observed 
7 days after trauma[16, 17]. At variance,  14 days or 30 days after noise exposure,  immediate 
local administration of steroid in a continuous delivery form (mini-osmotic pump, 
intratympanic injection, gelatin sponge) was shown to reduce hair cell loss (mostly outer hair 
cells), accelerate hearing recovery, but demonstrated various impacts on functional hearing 
outcomes (Table 1)[1, 13, 14]. Indeed Sendowski et al showed 16% of outer hair cell loss 
when methylprenisolone was administrated with an osmotic pump before and after acoustic 
trauma compared to a control group (46%) with an earlier hearing recovery but finally, similar 
auditory thresholds on all frequencies at 14 days[1]. In opposition, at similar severe acoustic 
trauma, Chi et al demonstrated at 3 and 4 weeks a stable hearing recovery and greater outer 
hair cell loss (67%) with a local dexamethasone administration. The correlation between 
functional and histological outcomes remains unclear. 
 With regard to delayed injection, from 24 h up to several days after noise exposure, a 
significant decrease in treatment efficiency was seen in albino guinea pigs[13, 16]. As 
previously described, early administration of corticosteroids can prevent anticipated acoustic 
trauma such as gunshot in the military operating field or in noise trauma surgery. However, 
Tran Ba Huy and Sauvaget found that the mean delay between first symptoms and medical 
visit was 3.1 days for idiopathic sensorineural hearing loss in 321 patients at emergency 
care[18]. Therefore, a 48-h delay between the acoustic trauma and dexamethasone injection 
was chosen in the present study to replicate patient clinics which present unpredictable noise-
induced hearing loss. Patients presenting unexpected acoustic trauma could be considered to 
have a sensorineural disorder. In this context, it is reasonable to assume that patients with 
acoustic trauma will not benefit from such local treatment. Indeed, dexamethasone locally 
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applied may act more like an otoprotective drug with a potential impact on temporary 
threshold shift rather than a permanent threshold shift after noise exposure. 
 
Conclusion 
The present study demonstrated a permanent hearing loss, at 8 kHz, 1 month after a mild 
noise trauma of 105 dB in albino guinea pigs. Dexamethasone in liposomes included in HA 
gel passively diffused through the round window 48 h after the acoustic trauma failed to 
promote additional or faster hearing recovery at 4, 16, 24 and 32 kHz compared to 
spontaneous recovery. The drug concentration in the inner ear and both the time and form of 
drug delivery must be carefully considered after acoustic trauma to ensure a potential benefit. 
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Figure Captions 
Fig. 1 Experimental protocol 
Fig. 2 Pre- and post-trauma ABR thresholds 
ABR thresholds in all animals were recorded before (dashed line, D-2) and after (solid line, 
D0) noise exposure (5 kHz, 100 dB, 1 h) and are shown for comparison (two-way ANOVA; 
**** p<0.0001 Tukey’s post-hoc test). Values are mean ± SEM (25 ears). 
 
Fig. 3 Post-trauma thresholds at D7 (solid black line) 
Pre-trauma ABR thresholds at D-2 (dashed gray line) and post-trauma ABR thresholds at D0 
(solid gray line) are shown for comparison. ABR thresholds at D7 (solid black line) are 
represented by (A) control group (trapezoid, eight ears), (B) HA group (squares, six ears), (C) 
HA-DexP group (diamonds, six ears), (D) HA-DexP-Lip group (triangles, five ears). Values 
are mean ± SEM. Hearing recovery was observed in the control group (A) in ABR thresholds 
at 16 and 24 kHz (D7) compared to post-trauma (D0) (two-way ANOVA; *p<0.05, 
**p<0.002; Tukey’s post-hoc test). 
 
Fig. 4 Post-trauma thresholds at D30 (solid black line) 
Pre-trauma ABR thresholds at D-2 (dashed gray line) and post-trauma ABR thresholds at D0 
(solid gray line) are shown for comparison. ABR thresholds at D30 (solid black line) are 
represented by (A) control group (trapezoid, eight ears), (B) HA group (squares, six ears), (C) 
HA-DexP group (diamonds, six ears), (D) HA-DexP-Lip group (triangles, five ears). Values 
are mean ± SEM. Total recovery at D30 was observed in all groups compared to pre-trauma 
thresholds (D-2), apart from 8 kHz frequency in each group, with no significant differences 
among all groups (two-way ANOVA; *p<0.02, **p<0.002, ***p<0.0001 Tukey’s post-hoc 
test). 
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Fig. 1 Experimental protocol  
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Fig. 2 Pre- and post-trauma ABR thresholds  
ABR thresholds in all animals were recorded before (dashed line, D-2) and after (solid line, D0) noise 
exposure (5 kHz, 100 dB, 1 h) and are shown for comparison (two-way ANOVA; **** p<0.0001 Tukey’s 
post-hoc test). Values are mean ± SEM (25 ears).  
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Fig. 3 Post-trauma thresholds at D7 (solid black line)  
Pre-trauma ABR thresholds at D-2 (dashed gray line) and post-trauma ABR thresholds at D0 (solid gray line) 
are shown for comparison. ABR thresholds at D7 (solid black line) are represented by (A) control group 
(trapezoid, eight ears), (B) HA group (squares, six ears), (C) HA-DexP group (diamonds, six ears), (D) HA-
DexP-Lip group (triangles, five ears). Values are mean ± SEM. Hearing recovery was observed in the control 
group (A) in ABR thresholds at 16 and 24 kHz (D7) compared to post-trauma (D0) (two-way ANOVA; 
*p<0.05, **p<0.002; Tukey’s post-hoc test).  
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Fig. 4 Post-trauma thresholds at D30 (solid black line)  
Pre-trauma ABR thresholds at D-2 (dashed gray line) and post-trauma ABR thresholds at D0 (solid gray line) 
are shown for comparison. ABR thresholds at D30 (solid black line) are represented by (A) control group 
(trapezoid, eight ears), (B) HA group (squares, six ears), (C) HA-DexP group (diamonds, six ears), (D) HA-
DexP-Lip group (triangles, five ears). Values are mean ± SEM. Total recovery at D30 was observed in all 
groups compared to pre-trauma thresholds (D-2), apart from 8 kHz frequency in each group, with no 
significant differences among all groups (two-way ANOVA; *p<0.02, **p<0.002, ***p<0.0001 Tukey’s 
post-hoc test).  
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Table. 1 Summary of the methods and results in noise-induced hearing loss guinea pig animal model 
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